Documentos relacionados

1. Biopsy of diffuse midline glioma is safe and impacts targeted therapy: a systematic review and meta-analysis.
2. Tumor antigens in glioma.
3. Identification of immune-related hub genes and construction of an immune-related gene prognostic index for low-grade glioma.
4. The impact of clinical trial enrollment on specialty palliative care utilization in pediatric patients with high-grade gliomas.
5. Isocitrate dehydrogenase-mutant glioma: Evolving clinical and therapeutic implications.
6. Quality indicators in neuro-oncology: Review of the literature and development of a new quality indicator set for glioma care through a two-round Delphi survey.
7. Effective extracellular vesicles in glioma: Focusing on effective ncRNA exosomes and immunotherapy methods for treatment.
8. Pyroptosis in glioma: Current management and future application.
9. Research Progress in Immunotherapy of Gliomas.
10. The landscape of current research on pediatric diffuse midline glioma: a quantitative analysis of shifts, leaders, and future avenues.